Beijing Wantai Biological Stock Fundamentals
| 603392 Stock | 73.17 1.41 1.96% |
Beijing Wantai Biological fundamentals help investors to digest information that contributes to Beijing Wantai's financial success or failures. It also enables traders to predict the movement of Beijing Stock. The fundamental analysis module provides a way to measure Beijing Wantai's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Beijing Wantai stock.
At present, Beijing Wantai's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 84 M, whereas Interest Income is forecasted to decline to about 83.6 M. Beijing | Select Account or Indicator |
Beijing Wantai Biological Company Current Valuation Analysis
Beijing Wantai's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Beijing Wantai Current Valuation | 86.21 B |
Most of Beijing Wantai's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beijing Wantai Biological is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Beijing Wantai Biological has a Current Valuation of 86.21 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is significantly lower than that of the firm.
Beijing Wantai Biological Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Beijing Wantai's current stock value. Our valuation model uses many indicators to compare Beijing Wantai value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beijing Wantai competition to find correlations between indicators driving Beijing Wantai's intrinsic value. More Info.Beijing Wantai Biological is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Beijing Wantai by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beijing Wantai's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Beijing Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beijing Wantai's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beijing Wantai could also be used in its relative valuation, which is a method of valuing Beijing Wantai by comparing valuation metrics of similar companies.Beijing Wantai is currently under evaluation in current valuation category among its peers.
Beijing Fundamentals
| Return On Equity | -0.0226 | ||||
| Return On Asset | -0.0154 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 86.21 B | ||||
| Shares Outstanding | 1.27 B | ||||
| Shares Owned By Insiders | 81.96 % | ||||
| Shares Owned By Institutions | 3.83 % | ||||
| Price To Book | 7.31 X | ||||
| Price To Sales | 38.96 X | ||||
| Revenue | 5.51 B | ||||
| Gross Profit | 9.99 B | ||||
| EBITDA | (122.77 M) | ||||
| Net Income | 1.25 B | ||||
| Total Debt | 81.14 M | ||||
| Book Value Per Share | 9.35 X | ||||
| Cash Flow From Operations | 1.54 B | ||||
| Earnings Per Share | (0.23) X | ||||
| Target Price | 61.4 | ||||
| Number Of Employees | 3.84 K | ||||
| Beta | 2.26 | ||||
| Market Capitalization | 97.1 B | ||||
| Total Asset | 15.71 B | ||||
| Retained Earnings | 7.57 B | ||||
| Working Capital | 7.63 B | ||||
| Net Asset | 15.71 B | ||||
| Last Dividend Paid | 0.32 |
About Beijing Wantai Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beijing Wantai Biological's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beijing Wantai using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beijing Wantai Biological based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 5.5 B | 4 B | |
| Cost Of Revenue | 792.1 M | 595.9 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Beijing Stock
Beijing Wantai financial ratios help investors to determine whether Beijing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Beijing with respect to the benefits of owning Beijing Wantai security.